BAK1 and lymphoma: Notably, deletion of BAX alone is sufficient to confer resistance to the MCL1 inhibitor S63845 in aggressive lymphoma models, even when BAK is intact, highlighting that BAX plays a non-redundant role in MCL1-dependent cell death [99].